Tshaj tawm
Rov qab mus rau lub Plaub Hlis 2022 Cov Neeg Koom Tes Kev Sib Txuas Lus Hloov Tshiab
Health Homes Program (HHP) Daim Ntawv Ntsuam Xyuas Thib Ob
On March 29, DHCS released the second HHP Interim Evaluation Report, which was independently developed by UCLA’s Center for Health Policy Research supported by The California Endowment. HHP was authorized under AB 361 (Chapter 642, Statutes of 2013) and approved by CMS under Section 2703 of the 2010 Patient Protection and Affordable Care Act.
Xyoo 2018, DHCS tau siv HHP los pab cov tswv cuab Medi-Cal MCP uas tsim nyog nrog cov kev xav tau nyuaj, suav nrog cov tib neeg uas muaj mob ntev thiab kev siv cov kev pabcuam siab. HHP ua haujlwm hauv 12 lub nroog California los ntawm 16 MCPs uas tau cog lus nrog Community-Based Care Management Entities (CB-CMEs). HHP tau poob rau lub Kaum Ob Hlis 31, 2021, thiab hloov mus rau ECM cov txiaj ntsig, tab sis DHCS ua tiav nws txoj kev cog lus los tsim cov kev ntsuam xyuas ywj pheej ntawm HHP.
DHCS released the first Interim HHP Evaluation Report in fall 2021. This second HHP interim evaluation report builds upon the findings of the first report and provides updates to enrollment patterns, demographics, and services HHP enrollees received originally reported in the first interim evaluation report. The second report also categorizes HHP enrollees based on their utilization of acute care services prior to HHP enrollment. The five distinct categories include enrollees considered super utilizers (6 percent of all enrollees), high utilizers (15 percent), moderate utilizers (35 percent), low utilizers (32 percent), and enrollees at risk for being a high utilizer (13 percent). UCLA found that enrollees considered super utilizers had 14.9 emergency department (ED) visits and 4.1 hospitalizations on average per year. Additionally, the second report also includes analyses of changes in HHP core metrics and estimated Medi-Cal payment measures compared to a control group. Findings indicated some improvements in metrics compared to the control. In particular, UCLA found greater declines for HHP participants in core metrics, such as ED visits and hospitalization rates, that were significantly greater compared to the control group. The final evaluation report will assess longer-term health outcomes and utilization trends of HHP enrollees and will be completed in spring 2023.